AsianScientist (Nov. 1, 2018) – China Electronics Data Service Co., Ltd. (CECD) and WuXi AppTec have set up a joint venture, CW Data, to offer one-stop big data solutions for the healthcare sector.
CW Data will provide healthcare data solutions to a range of industry stakeholders, including pharmaceutical and biotechnology companies, to further promote innovation and development in China’s healthcare ecosystem. It will integrate WuXi AppTec’s deep domain expertise in drug discovery and development, leveraging the latter’s data collection, data mining and data analytics capabilities to provide end-to-end technology solutions and services.
“The establishment of CW Data is an important cornerstone for CECD into healthcare analytics and big data. CW Data will combine big data, cloud computing, artificial intelligence and other cutting-edge technologies… to provide real world evidence and business insights to domestic and foreign biotechnology companies, drug distributors and medical device companies,” said Dr. Li Shifeng, chairman of CECD.
The partnership could also allow more new drugs and therapies to be launched in China within a shorter period of time.
“Through this collaboration, we will empower more doctors, scientists and healthcare companies by exploring more precise patient needs and providing more insightful healthcare data analytics. We hope to achieve the dream that every drug can be made, and every disease can be treated,” said Dr. Ge Li, chairman and CEO of WuXi AppTec.
Source: WuXi AppTec; Photo: Shutterstock.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.